SPECIFICITIES OF THE SUBSET PROFILE OF PERIPHERAL BLOOD IN PATIENTS WITH GLIOBLASTOMA: PATHOGENETIC AND CLINICAL ASSESSMENTS

par V. A. Chumakov, O. A. Pronina, I. A. Kachkov, A. G. Korshounov, B. V. Pineguin, I. I. Anan’eva, T. Elbeik, L. S. Metelitsa, A. E. Dorofeev, N. V. Gnouchev, S. V. Souchkov
Publié 2014

Histamine in cancer immunology and immunotherapy. Current status and new perspectives

par María de la Paz Sarasola, Mónica A. Táquez Delgado, Melisa B. Nicoud, Vanina A. Medina
Publié 2021

The Emerging Interplay Between Recirculating and Tissue-Resident Memory T Cells in Cancer Immunity: Lessons Learned From PD-1/PD-L1 Blockade Therapy and Remaining Gaps

par Silvia Gitto, Silvia Gitto, Ambra Natalini, Fabrizio Antonangeli, Francesca Di Rosa
Publié 2021

A Transcriptional Signature of IL-2 Expanded Natural Killer Cells Predicts More Favorable Prognosis in Bladder Cancer

par Yuhan Sun, Alexander James Sedgwick, Md Abdullah-Al-Kamran Khan, Yaseelan Palarasah, Stefano Mangiola, Alexander David Barrow
Publié 2021

Targeted Anti‐Tumor Immunotherapy Using Tumor Infiltrating Cells

par Yifan Xie, Feng Xie, Lei Zhang, Xiaoxue Zhou, Jun Huang, Fangwei Wang, Jin Jin, Long Zhang, Linghui Zeng, Fangfang Zhou
Publié 2021

Solid Tumor Microenvironment Can Harbor and Support Functional Properties of Memory T Cells

par Peter M. Sullivan, Steven James Reed, Vandana Kalia, Vandana Kalia, Surojit Sarkar, Surojit Sarkar, Surojit Sarkar
Publié 2021

Remodeling of the tumor microenvironment via disrupting Blimp1+ effector Treg activity augments response to anti-PD-1 blockade

par Michael L. Dixon, Lin Luo, Sadashib Ghosh, Jeffrey M. Grimes, Jonathan D. Leavenworth, Jianmei W. Leavenworth
Publié 2021

Combinational phototherapy and hypoxia-activated chemotherapy favoring antitumor immune responses

par Ma B, Sheng J, Wang P, Jiang Z, Borrathybay E
Publié 2019